Use

Somatostatin receptor type 2 (SSTR2) is a receptor for somatostatins‑14 and ‑28. Assessment of SSTR2 status via immunohistochemistry is diagnostically helpful in human neuroendocrine tumors and may have therapeutic implications, as overexpression is helpful for diagnosis and potentially influences therapeutic decision‑making.